Search Results - "Anson, Blake D."

Refine Results
  1. 1
  2. 2

    Development and Characterization of a Scaffold-Free 3D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes by Beauchamp, Philippe, Moritz, Wolfgang, Kelm, Jens M, Ullrich, Nina D, Agarkova, Irina, Anson, Blake D, Suter, Thomas M, Zuppinger, Christian

    Published in Tissue engineering. Part C, Methods (01-08-2015)
    “…Cardiomyocytes (CMs) are terminally differentiated cells in the adult heart, and ischemia and cardiotoxic compounds can lead to cell death and irreversible…”
    Get more information
    Journal Article
  3. 3

    Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism by ANDERSON, Corey L, DELISLE, Brian P, ANSON, Blake D, KILBY, Jennifer A, WILL, Melissa L, TESTER, David J, QIUMING GONG, ZHENGFENG ZHOU, ACKERMAN, Michael J, JANUARY, Craig T

    Published in Circulation (New York, N.Y.) (24-01-2006)
    “…The KCNH2 or human ether-a-go-go related gene (hERG) encodes the Kv11.1 alpha-subunit of the rapidly activating delayed rectifier K+ current (IKr) in the…”
    Get full text
    Journal Article
  4. 4

    Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels by Anson, Blake D, Ackerman, Michael J, Tester, David J, Will, Melissa L, Delisle, Brian P, Anderson, Corey L, January, Craig T

    “…Long QT syndrome (LQTS) is a cardiac repolarization disorder that can lead to arrhythmias and sudden death. Chromosome 7-linked inherited LQTS (LQT2) is caused…”
    Get more information
    Journal Article
  5. 5

    Thapsigargin Selectively Rescues the Trafficking Defective LQT2 Channels G601S and F805C by Delisle, Brian P., Anderson, Corey L., Balijepalli, Ravi C., Anson, Blake D., Kamp, Timothy J., January, Craig T.

    Published in The Journal of biological chemistry (12-09-2003)
    “…Several mutations in the human ether-a-go-go-related K+ channel gene (HERG or KCNH2) cause long QT syndrome (LQT2) by reducing the intracellular transport…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Biology of Cardiac Arrhythmias: Ion Channel Protein Trafficking by Delisle, Brian P, Anson, Blake D, Rajamani, Sridharan, January, Craig T, Marbán, Eduardo, Tomaselli, Gordon

    Published in Circulation research (11-06-2004)
    “…The mechanisms underlying normal and abnormal cardiac rhythms are complex and incompletely understood. Through the study of uncommon inheritable arrhythmia…”
    Get full text
    Journal Article
  9. 9

    Intragenic suppression of trafficking-defective KCNH2 channels associated with long QT syndrome by Delisle, Brian P, Slind, Jessica K, Kilby, Jennifer A, Anderson, Corey L, Anson, Blake D, Balijepalli, Ravi C, Tester, David J, Ackerman, Michael J, Kamp, Timothy J, January, Craig T

    Published in Molecular pharmacology (01-07-2005)
    “…Mutations in the KCNH2 or human ether-a-go-go-related gene-encoded K(+) channel reduce functional KCNH2 current (I(KCNH2)) to cause long QT syndrome (LQT2) by…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Stem Cells and Their Derivatives: A Renaissance in Cardiovascular Translational Research by Kattman, Steven J., Koonce, Chad H., Swanson, Bradley J., Anson, Blake D.

    “…Moving from the bench to the bedside is an expensive and arduous journey with a high risk of failure. One roadblock on the path of translational medicine is…”
    Get full text
    Journal Article
  12. 12

    Pharmacological rescue of human K+ channel long-QT2 mutations: Human ether-a-go-go-related gene rescue without block by RAJAMANI, Sridharan, ANDERSON, Corey L, ANSON, Blake D, JANUARY, Craig T

    Published in Circulation (New York, N.Y.) (18-06-2002)
    “…Defective protein trafficking is a consequence of gene mutations. Human long-QT (LQT) syndrome results from mutations in several genes, including the human…”
    Get full text
    Journal Article
  13. 13

    Comparison of HERG channel blocking effects of various β‐blockers – implication for clinical strategy by Kawakami, Kazunobu, Nagatomo, Toshihisa, Abe, Haruhiko, Kikuchi, Kan, Takemasa, Hiroko, Anson, Blake D, Delisle, Brian P, January, Craig T, Nakashima, Yasuhide

    Published in British journal of pharmacology (01-03-2006)
    “…β‐Blockers are widely used in the treatment of cardiovascular diseases. However, their effects on HERG channels at comparable conditions remain to be defined…”
    Get full text
    Journal Article
  14. 14

    An intronic mutation causes long QT syndrome by Zhang, Li, Vincent, G. Michael, Baralle, Marco, Baralle, Francisco E., Anson, Blake D., Benson, D. Woodrow, Whiting, Bryant, Timothy, Katherine W., Carlquist, John, January, Craig T., Keating, Mark T., Splawski, Igor

    “…The purpose of this research was to determine whether an intronic variant (T1945+6C) in KCNH2is a disease-causing mutation, and if expanded phenotyping…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Genetic basis for the origin of cardiac arrhythmias: implications for therapy by Mbai, Mackenzi, Rajamani, Sridharan, Delisle, Brian P, Anson, Blake D, Anderson, Corey, Makielski, Jonathan C, January, Craig T

    Published in Current cardiology reports (01-09-2002)
    “…The recognition of the role that genetic abnormalities play in the generation of cardiac arrhythmias and sudden cardiac death has evolved enormously over the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Opportunities for Human iPS Cells in Predictive Toxicology by Anson, Blake D., Kolaja, Kyle, Kamp, Timothy J.

    Published in Clinical pharmacology and therapeutics (23-03-2011)
    “…Toxicity assessment is a major challenge for cost-effective drug development, and there is great need for better tools to accurately predict adverse drug…”
    Get full text
    Journal Article